4
Changes in Ownership
Teladoc Health, Inc. Filed Acc 0001415889-23-009203
EVP, CORPORATE DEVELOPMENT sold 386 shares at $24.38 ($9,411)
- EVP, CORPORATE DEVELOPMENT acquired 1,347 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Turitz Andrew EVP, CORPORATE DEVELOPMENT | 2023-06-01 | Option exercise | +1,347 | 24,153 | D | ||
| Turitz Andrew EVP, CORPORATE DEVELOPMENT | 2023-06-02 | Sale | −386 | $24.38 | $9,411 | 23,767 | D |
| Derivatives | |||||||
| Turitz Andrew EVP, CORPORATE DEVELOPMENT | 2023-06-01 | Option exercise · Restricted Stock Units | −1,347 | 9,434 | D | ||
| Open-market sales · 386 sh · avg $24.38 · $9,411 | |||||||
Loading xslF345X04/form4-06052023_080639.xml…